Exchange: NASDAQ·Updated 07:30 PM EDT
PAHC logo

PAHC Phibro Animal Health Corp. - Ordinary Shares - Class A

$34.56
$0.115
(0.33%)
Today
Closed $34.56
$0.0025
(0.01%)
After Hours
Reported EarningsAug 26
Mkt Cap$1.4B
Vol635,513.00

About PAHC

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
46

Neutral Sentiment

How do you feel about PAHC?

DonCorleone77
$PAHC Phibro Animal Health sees FY27 adjusted EPS $3.41-$3.59, consensus $3.34 Sees FY27 revenue $1.55B-$1.6B, consensus $1.55B.
1
StocktwitsEarnings
$PAHC Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $0.53 down -7.02% YoY • Reported revenue of $396.75M up 4.77% YoY
DonCorleone77
$PAHC Phibro Animal Health reports Q4 adjusted EPS 85c, consensus 73c Reports Q4 revenue $396.7M, consensus $378.33M. "Fiscal 2026 was a year of meaningful progress for Phibro," said Dani Bendheim, President and Chief Executive Officer of Phibro Animal Health Corporation. "We delivered record net sales of $1.5 billion, increased Adjusted EBITDA by 39% to $255 million, expanded margins, and continued to improve our business. These results reflect the dedication of our employees around the world and the value of our diversified portfolio."

Advertisement|Remove ads.